Manufacturing / Pharmaceutical Preparations
Viatris Inc
VTRS
$15.38
+$0.00 (+0.00%)
19 B
Market Cap (Large Cap)
40%
IV Rank
37.4%
Implied Volatility
Aug 05
Next Earnings
Insider Trades
4 buys
2 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Apr 15, 2026 | Le Goff Corinne | Exercise | 3,644 | $0 | |
| Apr 15, 2026 | Le Goff Corinne | Tax_withholding | 1,617 | $22,412 | |
| Apr 15, 2026 | Le Goff Corinne | Exercise | 3,644 | $0 | |
| Apr 15, 2026 | Le Goff Corinne | Tax_withholding | 17,450 | $241,857 | |
| Apr 15, 2026 | Le Goff Corinne | Exercise | 39,344 | $0 | |
| Apr 15, 2026 | Le Goff Corinne | Other | 3,644 | $0 | |
| Apr 15, 2026 | Le Goff Corinne | Other | 1,617 | $22,412 | |
| Apr 15, 2026 | Le Goff Corinne | Other | 3,644 | $0 | |
| Apr 15, 2026 | Le Goff Corinne | Other | 17,450 | $241,857 | |
| Apr 15, 2026 | Le Goff Corinne | Other | 39,344 | $0 |
Politician Trades in VTRS
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| Nov 18, 2025 | Gil Cisneros | D | Purchase | $1K-$15K |
| Apr 23, 2025 | Ro Khanna | D | Purchase | $1K-$15K |
| Apr 08, 2025 | Robert P. Bresnahan | R | Sale | $1K-$15K |
| Mar 31, 2025 | Gil Cisneros | D | Sale | $1K-$15K |
| Feb 25, 2025 | Ro Khanna | D | Sale | $1K-$15K |
| Feb 25, 2025 | Robert P. Bresnahan | R | Purchase | $1K-$15K |
| Feb 19, 2025 | Ro Khanna | D | Sale | $1K-$15K |
| Jan 17, 2025 | Ro Khanna | D | Purchase | $1K-$15K |
| Nov 15, 2024 | Ro Khanna | D | Purchase | $1K-$15K |
| Oct 11, 2024 | Ro Khanna | D | Sale | $1K-$15K |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | $0.51 | $0.59 | +15.2% | Beat |
| Dec 31, 2025 | Q4 2025 | $0.54 | $0.57 | +4.8% | Beat |
| Sep 30, 2025 | Q3 2025 | $0.63 | $0.67 | +5.8% | Beat |
| Jun 30, 2025 | Q2 2025 | $0.57 | $0.62 | +9.4% | Beat |
| Mar 31, 2025 | Q1 2025 | $0.50 | $0.50 | +0.1% | Beat |
Track VTRS with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for VTRS and your entire portfolio.